All Other Countries was Cytosorbents’s largest region in fiscal 2025, bringing in $16.46M of $28.46M (58%).
| Geography | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Germany | $12.57M | $12.96M | $13.05M | $11.75M | ||||||
| All Other Countries | $11.12M | $12.10M | $14.78M | $16.46M | ||||||
| United States | $5.33M | $66.77K | $151.00K | $249.00K | ||||||
| Total | $29.01M | $25.13M | $27.98M | $28.46M |
Cytosorbents brought in $28.46M from its three regions in fiscal 2025, the year ended December 31, 2025. That was up 1.7% from $27.98M in fiscal 2024. All Other Countries was the largest at $16.46M (57.8%), ahead of Germany at $11.75M (41.3%) and United States at $249.00K (0.9%).
Compared with fiscal 2024, All Other Countries grew 11.4% to $16.46M, while Germany fell 10.0% to $11.75M. From fiscal 2022 to 2025, combined revenue from these regions fell from $29.01M to $28.46M, a compound annual decline of 0.6%. All Other Countries' share of the total rose from 38.3% to 57.8%.
Distributors/Strategic Partners was Cytosorbents’s largest revenue line in fiscal 2025, bringing in $16.46M of $28.21M (58%).
| Major Customers | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Direct | $12.57M | $12.96M | $13.05M | $11.75M | ||||||
| Distributors/Strategic Partners | $11.12M | $12.10M | $14.78M | $16.46M | ||||||
| Distributors & Strategic Partners | — | — | — | — | ||||||
| United States Government Agencies | $5.33M | — | — | — | ||||||
| Total | $29.01M | $25.06M | $27.83M | $28.21M |
Cytosorbents brought in $28.21M from its two revenue lines in fiscal 2025, the year ended December 31, 2025. That was up 1.4% from $27.83M in fiscal 2024. Distributors/Strategic Partners was the largest at $16.46M (58.3%), ahead of Direct at $11.75M (41.7%).
Compared with fiscal 2024, Distributors/Strategic Partners grew 11.4% to $16.46M, while Direct fell 10.0% to $11.75M.
Cytosorbents stopped reporting United States Government Agencies as a separate revenue line after fiscal 2022, when it brought in $5.33M.
Cytosorbents (CTSO) reports its revenue by geography and by major customers. In fiscal 2025, All Other Countries was its largest region, bringing in $16.46M (57.8% of the total), followed by Germany at $11.75M (41.3%).
All Other Countries was Cytosorbents' largest region in fiscal 2025, bringing in $16.46M, or 57.8% of the $28.46M total across its three regions.
Distributors/Strategic Partners was Cytosorbents' largest revenue line in fiscal 2025, bringing in $16.46M, or 58.3% of the $28.21M total across its two revenue lines.
All Other Countries grew faster than Germany in fiscal 2025, up 11.4% from $14.78M to $16.46M. Germany fell 10.0% to $11.75M.
Every figure comes from Cytosorbents' annual financial filings, as reported. Each line keeps the name Cytosorbents gives it, and years follow its fiscal calendar.
Cytosorbents' revenue by geography goes back to fiscal 2016, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.